This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_MULTIPLE_MYELOMA_PLASMA_CELL_EXALLC for full statistics.
Multiple myeloma and malignant plasma cell neoplasms
CD2_MULTIPLE_MYELOMA_PLASMA_CELL
multiple myeloma: A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1646 |
4. Check minimum number of eventsNone |
1646 |
5. Include endpointsNone |
1646 |
6. Filter based on genotype QC (FinnGen only) |
1646 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Myeloma multiplex et neoplasmata maligna plasmacytorum
Similar endpoints
↥List of similar endpoints to
Multiple myeloma and malignant plasma cell neoplasms
based on the number of shared cases.
Similar with more cases:
- Multiple myeloma and malignant plasma cell neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1646 | 722 | 924 |
| Unadjusted period prevalence (%) | 0.34 | 0.25 | 0.41 |
| Median age at first event (years) | 69.18 | 68.21 | 69.95 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1545
- Matched controls
- 15448
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L04AX04
ATC
lenalidomide; oral
+∞
323.0
559
*
C90.0
ICD-10 Finland
Multiple myeloma
4503599627370496.0
323.0
1384
*
153
Kela drug reimbursment
Lenalidomid
+∞
323.0
607
*
H02AB02
ATC
dexamethasone; systemic
21.2
323.0
852
846
XW000
NOMESCO Finland
Bone marrow biopsy
45.9
323.0
737
301
329
Kela drug reimbursment
Lenalidomide
+∞
323.0
378
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
7179.8
323.0
784
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
113.4
323.0
1074
304
L03AA02
ATC
filgrastim; parenteral
43.5
323.0
449
144
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
537.0
316.9
305
7
WW300
NOMESCO Finland
Transfer of autologic stem cells
540.1
279.5
270
6
M04AA01
ATC
allopurinol; systemic
8.4
271.4
735
1505
A04AA01
ATC
ondansetron; systemic, rectal
14.1
264.7
489
491
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
14.5
258.7
470
452
AA1AA
NOMESCO Finland
Head X-ray examination
79.5
241.0
270
41
J05AB01
ATC
aciclovir; systemic
6.7
225.1
730
1823
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
45.2
213.6
264
70
L01AA03
ATC
melphalan; systemic
+∞
208.1
195
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
161.9
190.5
198
14
ZX112
NOMESCO Finland
Subcutaneous
26.2
189.6
269
123
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
18.8
183.6
292
189
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
21.5
179.8
272
152
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
392.6
178.4
176
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.6
168.1
931
3859
N02AA05
ATC
oxycodone; systemic
5.4
165.0
613
1667
ZX120
NOMESCO Finland
Intravenous
6.7
144.9
417
806
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
35.0
137.7
180
58
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
135.4
128
*
393
Kela drug reimbursment
Pomalidomide
+∞
131.1
124
*
J05AB11
ATC
valaciclovir; oral
5.6
130.5
443
1039
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
27.6
130.1
181
74
YNB10
NOMESCO Finland
Collection of stem cells for transplant
671.2
127.3
124
*
WW500
NOMESCO Finland
Blood transfusion
9.9
126.8
271
324
B03XA02
ATC
darbepoetin alfa; parenteral
17.9
123.3
198
126
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
12.3
120.7
229
216
1507
Kela drug reimbursment
Pomalidomide
+∞
118.3
112
*
R50.9
ICD-10 Finland
Fever, unspecified
4.8
117.5
466
1278
1XX32
NOMESCO Finland
NA
1205.1
116.2
112
*
M05BA02
ATC
clodronic acid; systemic
77.9
114.4
129
18
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
143.1
112.8
119
9
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.9
112.2
429
1125
L04AX06
ATC
pomalidomide; oral
+∞
111.8
106
*
WW409
NOMESCO Finland
Other aferesis
202.9
110.0
113
6
WW402
NOMESCO Finland
Leucoferesis
1078.2
104.5
101
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.0
103.6
278
469
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
31.4
103.0
138
48
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.9
102.4
319
655
WF049
NOMESCO Finland
Radiotherapy of metastasis
9.4
101.6
222
271
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.1
100.6
361
872
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.8
99.4
227
298
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
99.0
94
*
ZX108
NOMESCO Finland
Inhalation
46.8
98.8
121
28
L04AX02
ATC
thalidomide; oral
908.3
88.6
86
*
WW200
NOMESCO Finland
Immunization
11.4
81.3
158
153
398
Kela drug reimbursment
Ixazomib
+∞
80.9
77
*
212
Kela drug reimbursment
Gout
10.3
77.1
158
169
1505
Kela drug reimbursment
Ixazomib
+∞
75.6
72
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
75.4
930
5535
B03XA01
ATC
erythropoietin; parenteral
22.7
75.1
110
52
B01AB05
ATC
enoxaparin; parenteral
2.8
74.5
697
3507
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
73.2
617
2899
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
13.0
67.9
123
102
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
67.3
335
1066
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
67.2
64
*
L01AA01
ATC
cyclophosphamide; systemic
34.5
65.3
85
26
5BA08
NOMESCO Finland
NA
42.1
64.2
80
20
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.7
61.3
149
211
JN4AD
NOMESCO Finland
Body CT examination
4.2
60.9
253
681
J01MA12
ATC
levofloxacin; systemic
2.9
60.7
471
2049
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.5
60.7
191
383
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
58.7
56
*
B74
ICPC
Malignant neoplasm blood other
129.1
58.3
62
5
Z52.89
ICD-10 Finland
Donor of other organ or tissue
189.9
53.3
55
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.5
53.0
168
338
C03CA01
ATC
furosemide; systemic
2.4
53.0
691
3946
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
52.0
398
1691
A02BC02
ATC
pantoprazole; systemic
2.4
51.8
1124
8174
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
49.9
602
3281
TK800
NOMESCO Finland
Hemodialysis
8.5
48.7
110
138
J01MA14
ATC
moxifloxacin; systemic
3.6
48.7
242
753
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
17.0
48.6
78
48
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
11.4
47.2
90
83
M05BX04
ATC
denosumab; parenteral
4.6
46.4
172
409
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
8.0
46.3
108
143
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
45.7
316
1245
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
28.0
45.4
62
23
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.3
45.3
146
298
GA5AA
NOMESCO Finland
Rib X-ray examination
35.4
45.0
58
17
L01XX50
ATC
[U] ixazomib; oral
+∞
45.0
43
*
C90
ICD-10 Finland
Multiple myeloma and malignant plasma cell neoplasms
+∞
45.0
43
*
1CX01
NOMESCO Finland
NA
450.1
44.4
44
*
WF004
NOMESCO Finland
Palliative radiotherapy
8.2
44.3
102
132
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.5
43.8
71
45
B01AB10
ATC
tinzaparin; parenteral
3.9
43.3
191
534
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.8
41.6
146
327
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
39.1
436
2226
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
9.3
39.1
83
94
N08.1*C90.0
ICD-10 Finland
Glomerular disorders in multiple myeloma
+∞
38.7
37
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
51.4
37.7
45
9
NB6AA
NOMESCO Finland
Humerus X-ray examination
7.1
36.3
91
134
A41.9
ICD-10 Finland
Sepsis, unspecified
4.8
36.1
126
280
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.8
34.2
156
447
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
36.8
33.8
43
12
A05AA02
ATC
ursodeoxycholic acid; oral
11.3
33.6
64
59
E83.50
ICD-10 Finland
Hypercalcemia
10.0
33.0
67
70
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
9.7
32.0
66
71
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
24.3
31.9
45
19
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
22.5
31.9
46
21
Z51.5
ICD-10 Finland
Palliative care
3.2
31.6
176
588
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
31.6
630
4043
L01XG03
ATC
ixazomib; oral
+∞
31.3
30
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.2
31.3
381
1994
127
Kela drug reimbursment
Transplant complication
8.5
31.2
69
84
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
163.2
30.8
32
*
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
+∞
30.3
29
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
29.9
221
890
D70.89
ICD-10 Finland
Neutropenic splenomegaly
11.8
29.7
55
48
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
22.1
29.7
43
20
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
29.3
28
*
NF3AA
NOMESCO Finland
Femur X-ray examination
6.3
28.6
78
130
5BA03
NOMESCO Finland
NA
+∞
28.2
27
*
N16.1*C90.0
ICD-10 Finland
Renal tubulo-interstitial disorders in multiple myeloma
+∞
28.2
27
*
2030A
ICD-9 Finland
Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma
+∞
28.2
27
*
A06AD11
ATC
lactulose; oral
2.2
27.9
338
1754
E85.89
ICD-10 Finland
Other amyloidosis
147.6
27.7
29
*
H02AB06
ATC
prednisolone; systemic
1.8
27.3
776
5535
JN4BD
NOMESCO Finland
Extensive body CT
2.4
27.0
255
1173
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
20.5
27.0
40
20
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.3
25.9
139
452
E85.9
ICD-10 Finland
Amyloidosis, unspecified
20.5
25.7
38
19
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.7
25.4
74
134
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
18.2
25.3
39
22
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
25.2
228
1023
XX3DW
NOMESCO Finland
Time consuming IT work
2.5
25.1
224
997
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
59.0
25.1
29
5
1AA01
NOMESCO Finland
NA
71.1
24.9
28
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
254.0
24.7
25
*
H02AB09
ATC
hydrocortisone; systemic
5.6
24.5
73
136
N03AX16
ATC
pregabalin; oral
1.9
23.8
416
2483
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
5.4
23.8
73
141
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
23.7
723
5188
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.1
23.5
76
156
NBJ60
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus
33.9
23.4
30
9
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
12.3
23.3
42
35
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.4
23.2
86
204
ZXD05
NOMESCO Finland
Urgent procedure
1.8
22.9
508
3286
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
9.5
22.9
47
51
NB4AA
NOMESCO Finland
Scapula X-ray examination
26.3
22.7
31
12
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
22.7
503
3251
M49.5
ICD-10 Finland
Collapsed vertebra in diseases classified elsewhere
233.2
22.7
23
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
23.3
22.6
32
14
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
27.8
22.3
30
11
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
7.4
22.1
53
74
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.1
21.5
87
224
L03AA13
ATC
pegfilgrastim; parenteral
3.9
21.5
91
244
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.7
21.4
152
594
N02AX02
ATC
tramadol; systemic, rectal
1.7
21.2
686
4952
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
21.1
197
893
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.2
21.1
81
199
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
20.8
97
283
N18.8
ICD-10 Finland
Other chronic renal failure
4.0
20.7
86
227
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
20.3
194
889
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
6.8
19.8
50
76
A11CC03
ATC
alfacalcidol; systemic
4.4
19.4
72
171
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
19.3
156
654
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.6
19.2
67
150
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.7
19.1
135
523
3XA02
NOMESCO Finland
NA
55.7
18.9
22
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.2
18.9
73
181
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
6.7
18.8
48
74
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
18.6
394
2476
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
192.2
18.6
19
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
8.2
18.5
41
51
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.9
18.5
77
204
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.3
18.4
56
108
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
18.4
505
3438
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
12.0
18.3
33
28
L03AB05
ATC
interferon alfa-2b; parenteral
17.8
18.3
28
16
N17.8
ICD-10 Finland
Other acute renal failure
7.0
18.0
44
64
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
17.7
17
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.4
17.7
64
149
EBA10
NOMESCO Finland
Surgical removal of tooth
2.4
16.8
147
645
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
64.0
16.8
19
*
M82.0*C90.0
ICD-10 Finland
Osteoporosis in multiple myelomatosis
+∞
16.7
16
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
16.6
244
1344
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.2
16.6
51
100
NA2AD
NOMESCO Finland
Thoracic spine CT examination
10.2
16.4
32
32
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
20.3
16.4
24
12
L04AD01
ATC
ciclosporin; systemic
5.0
16.2
52
107
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
30.4
16.1
21
7
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.7
16.1
70
194
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
33.7
15.7
20
6
6BA02
NOMESCO Finland
NA
17.4
15.6
24
14
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
5.8
15.6
44
78
L01BB05
ATC
fludarabine; systemic
26.6
15.6
21
8
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
8.6
15.5
33
39
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
15.4
318
1969
N05CF01
ATC
zopiclone; oral
1.6
15.4
538
3866
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
14.9
15.4
25
17
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
15.3
122
507
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.3
14.9
45
87
A07AA02
ATC
nystatin; oral
2.4
14.8
132
584
B73
ICPC
Leukaemia
32.0
14.8
19
6
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
57.2
14.8
17
*
N08.1
ICD-10 Finland
Glomerular disorders in neoplastic diseases
+∞
14.6
14
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
14.3
14.5
24
17
A79
ICPC
Malignancy NOS
5.4
14.4
43
82
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
27.4
14.3
19
7
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
14.2
147
698
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
53.8
13.8
16
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
13.8
165
837
WZC30
NOMESCO Finland
Teaching
1.9
13.7
218
1233
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.2
13.7
36
59
N19
ICD-10 Finland
Unspecified kidney failure
2.8
13.7
88
324
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
13.6
314
2003
L71
ICPC
Malignant neoplasm musculoskeletal
75.8
13.6
15
*
9731/3-C42.1
ICD-O-3
Plasmacytoma, NOS, of bone marrow
+∞
13.6
13
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
13.4
477
3416
H02AB07
ATC
prednisone; oral
1.8
13.2
240
1419
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
13.0
266
1635
R80
ICD-10 Finland
Isolated proteinuria
9.4
13.0
26
28
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
50.4
12.8
15
*
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
7.3
12.8
30
42
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.2
12.8
66
211
B02.9
ICD-10 Finland
Zoster without complication
2.4
12.7
112
492
NB4DA
NOMESCO Finland
Bilateral scapula X-ray examination
+∞
12.5
12
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.9
12.4
34
59
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.0
12.3
71
244
Z3231
NOMESCO Finland
Registered nurse
1.6
12.3
419
2961
J02AC03
ATC
voriconazole; systemic
16.0
12.1
19
12
SPAT1088
SPAT
Blood transfusion
8.2
12.1
26
32
SPAT1255
SPAT
Intravenous administration of medicine
2.2
12.0
125
594
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
12.0
90
365
ZXE00
NOMESCO Finland
One hour or less
1.5
11.9
570
4338
ZX080
NOMESCO Finland
Image guided radiotherapy
3.8
11.9
50
136
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.8
11.9
49
131
TGC00
NOMESCO Finland
Bronchial lavation
3.3
11.8
59
184
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.4
11.8
25
30
H02AB04
ATC
methylprednisolone; systemic
1.8
11.8
227
1366
ZY010
NOMESCO Finland
Hospital outpatient
3.1
11.7
65
219
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
16.5
11.7
18
11
A02BC01
ATC
omeprazole; systemic
1.5
11.6
437
3151
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
12.6
11.6
20
16
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
19.1
11.6
17
9
20399
ICD-8 Finland
Multiple myeloma
+∞
11.5
11
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
13.7
11.5
19
14
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
11.4
98
426
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
11.4
106
479
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
11.4
248
1550
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.1
11.3
43
107
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
6.3
11.2
29
47
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.6
11.1
78
304
L01AA02
ATC
chlorambucil; oral
11.2
11.0
20
18
A41.8
ICD-10 Finland
Other specified sepsis
4.0
11.0
43
110
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
7.5
11.0
25
34
A06AH03
ATC
naloxegol; oral
4.9
10.8
34
70
N02BE01
ATC
paracetamol; systemic, rectal
1.6
10.7
1263
11457
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
17.9
10.7
16
9
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.1
10.6
40
99
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.2
10.6
55
177
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
14.3
10.5
17
12
ZYC01
NOMESCO Finland
Remote contact by phone
2.7
10.4
70
267
JN4CD
NOMESCO Finland
Very extensive body CT
2.5
10.4
81
337
J01CA04
ATC
amoxicillin; systemic
1.5
10.3
1093
9634
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.5
10.3
47
138
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
23.5
10.2
14
6
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
7.5
10.2
23
31
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.4
10.1
47
140
A28
ICPC
Limited function/disability NOS
1.6
10.1
277
1841
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
4.5
10.0
34
77
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.2
9.9
51
164
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
6.8
9.9
24
36
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
9.9
125
648
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
8.8
9.8
20
23
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.5
9.8
33
74
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
6.6
9.7
24
37
N18.0
ICD-10 Finland
End-stage renal disease
4.5
9.7
33
75
WF099
NOMESCO Finland
Other radiotherapy
6.0
9.5
25
42
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.8
9.5
30
63
3AA13
NOMESCO Finland
NA
17.6
9.4
14
8
1XX45
NOMESCO Finland
NA
+∞
9.4
9
*
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
9.4
9
*
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
8.1
9.3
20
25
WX110
NOMESCO Finland
Local anesthesy
1.4
9.2
880
7520
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.0
9.2
50
168
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
4.0
9.1
35
89
H26.3
ICD-10 Finland
Drug-induced cataract
7.8
9.1
20
26
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
5.0
9.1
28
57
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
9.1
9.0
18
20
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
36.9
9.0
11
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.0
9.0
51
174
ECB20
NOMESCO Finland
Oral alveoplasty
5.8
8.9
24
42
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
12.6
8.9
15
12
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
8.7
8.8
18
21
B99
ICPC
Blood/lymph/spleen disease other
10.8
8.8
16
15
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
9.5
8.8
17
18
A07AA09
ATC
vancomycin; oral
3.9
8.7
34
88
1XC02
NOMESCO Finland
NA
5.8
8.6
23
40
L01BB02
ATC
mercaptopurine; oral
8.3
8.6
18
22
L03AA04
ATC
NA
16.4
8.6
13
8
A12AA04
ATC
calcium carbonate; oral
3.4
8.5
39
116
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
8.5
105
541
372
Kela drug reimbursment
Idelalisib
27.7
8.5
11
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.8
8.4
34
91
M54.5
ICD-10 Finland
Low back pain
1.4
8.4
408
3071
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
8.4
88
421
R06.0
ICD-10 Finland
Dyspnoea
1.5
8.4
375
2777
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
8.4
303
2143
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
7.9
8.4
18
23
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
7.9
8.4
18
23
NAR00
NOMESCO Finland
Complete excision of tumour of bone or cartilage of spine, unspecified
+∞
8.3
8
*
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
8.3
8
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
6.2
8.3
21
34
ZX070
NOMESCO Finland
Intensity modified radiotherapy
3.1
8.3
44
146
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
10.8
8.3
15
14
WVA20
NOMESCO Finland
Medicine administration
3.1
8.3
43
141
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
7.1
8.3
19
27
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
8.2
88
428
L01XE27
ATC
[U] ibrutinib; oral
14.5
8.2
13
9
WX892
NOMESCO Finland
Monitored bed care
1.9
8.2
120
656
R4110
NOMESCO Finland
Physiotherapy
1.4
8.1
383
2863
S42.3
ICD-10 Finland
Fracture of shaft of humerus
4.2
8.1
29
70
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
8.1
245
1664
L01XX47
ATC
[U] idelalisib; oral
33.5
8.1
10
*
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
17.3
8.1
12
7
390
Kela drug reimbursment
Ibrutinib
11.8
8.1
14
12
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
9.0
8.0
16
18
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
22.1
8.0
11
5
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
7.9
98
503
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
7.9
148
880
J01DB01
ATC
cefalexin; oral
1.4
7.9
1134
10249
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
7.9
151
904
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
7.9
132
758
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
7.8
206
1350
D64.8
ICD-10 Finland
Other specified anaemias
3.4
7.8
36
108
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.3
7.8
70
314
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
4.7
7.8
25
54
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
7.8
264
1839
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
10.9
7.8
14
13
WF002
NOMESCO Finland
Radical radiotherapy
2.1
7.8
88
436
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.6
7.7
25
55
N03AX12
ATC
gabapentin; oral
1.6
7.6
216
1443
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
7.6
326
2384
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
11.9
7.6
13
11
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.6
239
1637
J20.4
ICD-10 Finland
Acute bronchitis due to parainfluenza virus
80.4
7.4
8
*
L04AA06
ATC
mycophenolic acid; systemic
3.5
7.4
33
97
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.3
7.4
21
40
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
7.3
115
648
1512
Kela drug reimbursment
Ibrutinib
10.9
7.3
13
12
GA5DA
NOMESCO Finland
Bilateral rib X-ray exmaination
+∞
7.3
7
*
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
4.5
7.3
24
54
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
7.3
99
529
V03AE01
ATC
polystyrene sulfonate; oral
3.7
7.2
29
79
L01XX52
ATC
venetoclax; oral
30.1
7.1
9
*
399
Kela drug reimbursment
Venetoclax
20.1
7.1
10
5
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.4
7.1
32
95
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
8.0
7.1
15
19
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
3.2
7.1
35
112
L04AA01
ATC
[U] ciclosporin; systemic
3.5
7.0
31
91
F43.29
ICD-10 Finland
Adaptation disorder UNS
4.0
7.0
26
66
Z2221
NOMESCO Finland
Medical doctor
1.4
7.0
374
2857
B34.9
ICD-10 Finland
Viral infection, unspecified
3.2
6.9
34
108
L28
ICPC
Limited function/disability (L)
1.5
6.9
247
1738
J12.8
ICD-10 Finland
Other viral pneumonia
5.5
6.9
19
35
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.7
6.9
44
164
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.1
6.8
35
115
Z2446
NOMESCO Finland
Social worker
1.9
6.8
90
477
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
6.1
6.8
17
28
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
5.7
6.8
18
32
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
40.2
6.8
8
*
R93.7
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of musculoskeletal system
16.8
6.7
10
6
J02AC01
ATC
fluconazole; systemic
1.4
6.7
432
3401
1AA09
NOMESCO Finland
NA
22.6
6.7
9
*
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
6.7
102
569
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
3.4
6.6
30
90
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
6.6
67
321
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.6
464
3704
B01.9
ICD-10 Finland
Varicella without complication
12.3
6.6
11
9
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.7
6.5
42
158
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.9
6.5
15
22
L03AA10
ATC
lenograstim; parenteral
70.1
6.4
7
*
N08.2*D89.82
ICD-10 Finland
Nepropathy caused by deposition of the light chain of the immunoglobulins
70.1
6.4
7
*
J12.2
ICD-10 Finland
Parainfluenza virus pneumonia
70.1
6.4
7
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
7.4
6.4
14
19
TK810
NOMESCO Finland
Hemofiltration
5.2
6.3
18
35
E83.51
ICD-10 Finland
Hypocalcemia
6.0
6.3
16
27
GA6AA
NOMESCO Finland
Sternal X-ray examination
11.1
6.3
11
10
9733/3-C42.1
ICD-O-3
Plasma cell leukemia of bone marrow
+∞
6.3
6
*
E85.0
ICD-10 Finland
Non-neuropathic heredofamilial amyloidosis
+∞
6.3
6
*
C08CA01
ATC
amlodipine; oral
1.3
6.2
569
4719
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
5.0
6.2
18
36
NB3AA
NOMESCO Finland
Clavicle X-ray examination
3.8
6.2
24
64
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.9
6.2
81
430
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.3
6.2
28
85
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.2
6.1
21
50
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
6.1
149
959
R04.0
ICD-10 Finland
Epistaxis
1.7
6.1
115
688
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
4.0
6.1
22
55
A04AA02
ATC
granisetron; systemic, transdermal
1.9
6.1
84
454
ZX100
NOMESCO Finland
Oral
3.4
6.0
27
81
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.0
588
4916
A98
ICPC
Health maint/preventive medicine
0.7
6.0
1182
12623
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017143) Hepatitis C virus Ab [Presence] in Serum
568
1045
7.77
318.43
1.8
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
786
1998
6.62
317.81
11.2
5.4
mmol/l
1.1
1.0
4.58
759
1833
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
381
441
10.94
314.75
20.0
1.5
g/l
0.0
0.0
1.21
358
399
(40760888) Immunoglobulin light chains.free panel - Serum
918
366
55.45
307.65
17.3
1.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
409
494
10.69
307.65
19.1
1.5
g/l
37.7
37.2
0.92
376
419
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
330
264
15.38
307.65
5.9
5.9
iu/ml
289.1
859.1
0.69
72
44
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1000
491
50.35
307.65
19.2
1.7
ratio
27.1
1.5
2.19
81
42
(3017704) Immunofixation for Urine
291
87
40.42
307.65
4.0
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
612
573
16.41
307.65
17.4
1.5
g/l
2.9
3.2
6.19
416
456
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
425
464
12.00
307.65
18.9
1.5
g/l
0.2
0.0
2.84
396
420
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
197
19
117.64
307.65
1.2
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
282
168
20.05
307.65
1.4
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
248
23
126.78
307.65
4.7
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
586
585
15.00
307.65
17.7
1.5
g/l
10.7
10.5
0.22
477
496
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
591
1094
7.87
307.65
1.9
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
603
260
36.02
307.65
1.7
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
1005
506
49.43
307.65
19.9
1.7
mg/l
246.5
46.7
2.04
874
414
(3004588) Protein electrophoresis panel - Serum or Plasma
1042
1103
24.02
307.65
19.2
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
867
337
53.25
307.65
4.9
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
762
747
18.13
307.65
6.1
1.7
g/l
0.8
1.7
4.47
645
675
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
672
618
17.69
307.65
16.4
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1005
507
49.33
307.65
19.9
1.7
mg/l
115.1
46.1
3.11
873
417
(3007164) IgA [Mass/volume] in Serum or Plasma
840
2148
6.94
307.65
7.5
1.3
g/l
3.3
2.7
1.69
737
1224
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
672
619
17.66
307.65
16.5
1.5
g/l
7.0
7.5
5.26
482
461
(3005719) IgG [Mass/volume] in Serum or Plasma
912
935
20.63
307.65
10.9
2.4
g/l
12.4
10.5
4.94
869
843
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1021
1810
13.22
307.65
12.1
3.6
u/l
230.0
248.6
2.37
1002
1703
(3021879) Hepatitis B virus core Ab [Presence] in Serum
499
658
10.45
307.65
1.7
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1061
1320
20.80
307.65
20.5
1.9
g/l
67.3
66.2
2.57
1040
1191
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
672
617
17.72
307.65
16.4
1.5
g/l
4.1
3.8
0.46
413
447
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
656
521
20.27
307.65
16.1
1.7
g/l
6.8
0.8
34.75
543
442
(3027945) Reticulocytes/100 erythrocytes in Blood
851
1926
8.08
307.65
4.9
2.4
%
1.7
1.8
3.29
811
1697
(21494434) Karyotype in Bone marrow
319
154
25.45
307.65
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
749
134
101.73
307.65
5.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
524
57
134.40
307.65
3.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
741
1444
8.51
307.65
4.6
2.5
e9/l
61.8
68.7
5.24
601
1127
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
368
436
10.58
298.09
20.6
1.5
g/l
0.0
0.0
0.00
358
398
(3036603) Volume of Urine
201
80
28.48
292.38
3.5
1.3
ml
1916.4
1793.8
0.26
40
22
(3048879) Bone marrow aspiration report
169
47
39.96
274.47
2.3
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
577
1261
6.51
268.33
1.8
1.5
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
136
12
123.45
268.26
3.9
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
138
16
94.05
264.10
1.7
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1011
3690
5.51
258.35
9.5
2.8
umol/l
3310.0
7656.2
1.67
978
3122
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
133
15
96.37
255.30
9.8
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
290
343
10.05
233.03
2.7
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
294
358
9.78
230.96
2.6
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
218
9
278.87
217.74
1.4
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
227
219
11.86
210.45
1.6
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
497
1162
5.69
209.93
8.4
4.0
%
1.0
1.0
0.21
335
366
(3012095) Magnesium [Moles/volume] in Serum or Plasma
728
2366
4.72
205.53
6.1
3.1
mmol/l
0.8
0.8
1.67
701
2195
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
230
250
10.53
195.82
1.4
1.2
u/l
87.7
40.3
2.55
219
214
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
234
263
10.21
194.35
2.8
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
226
250
10.32
189.82
4.5
3.9
%
1.8
1.4
0.53
188
199
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
204
209
11.00
180.86
2.6
3.1
u/ml
227.2
1665.4
0.64
12
18
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
276
421
7.68
177.99
1.9
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
261
386
7.85
172.85
1.5
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
139
82
18.42
170.30
2.0
1.6
%
28.3
44.8
1.68
12
12
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
443
1115
5.07
168.57
2.3
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1004
4630
4.00
164.97
15.0
5.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
169
153
12.20
162.57
3.0
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
422
1050
5.06
162.33
9.0
3.8
%
0.8
0.7
0.47
240
261
(3021440) Promyelocytes/100 leukocytes in Blood
431
1096
4.97
161.41
8.9
4.1
%
0.1
0.1
0.24
310
332
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
171
162
11.66
159.59
3.0
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1173
6194
4.11
153.52
18.4
6.1
%
9.8
8.9
11.93
1149
5753
(3006504) Eosinophils/100 leukocytes in Blood
1170
6172
4.10
153.25
17.5
5.8
%
2.6
2.8
2.27
1144
5706
(3022096) Basophils/100 leukocytes in Blood
1149
6012
4.02
151.75
17.3
5.8
%
0.6
0.7
0.46
1122
5570
(3001604) Monocytes [#/volume] in Blood
1203
6513
4.15
150.49
17.7
5.5
e9/l
0.5
0.6
16.49
1123
5533
(3006315) Basophils [#/volume] in Blood
1205
6541
4.14
149.91
17.8
5.5
e9/l
0.0
0.0
28.94
1124
5567
(3002030) Lymphocytes/100 leukocytes in Blood
1176
6305
4.03
148.41
17.8
6.0
%
28.7
26.3
7.86
1149
5817
(3018010) Neutrophils/100 leukocytes in Blood
1159
6202
3.94
145.52
16.3
5.7
%
54.5
58.4
18.37
1132
5755
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
147
127
12.61
145.46
3.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
147
127
12.61
145.46
3.3
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
147
127
12.61
145.46
3.3
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
683
2611
3.76
144.57
3.3
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1218
6759
4.08
144.22
18.8
5.8
e9/l
0.2
0.2
22.88
1143
5852
(3019198) Lymphocytes [#/volume] in Blood
1207
6668
4.04
143.62
17.9
5.6
e9/l
1.8
1.9
0.54
1138
5790
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
343
793
5.20
142.73
2.4
1.7
g/l
1.4
1.6
2.38
308
683
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
112
62
19.31
141.09
3.7
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
120
77
16.73
140.67
2.0
2.8
%
31.2
39.5
1.30
30
30
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
111
61
19.44
140.29
3.6
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
111
61
19.44
140.29
3.6
1.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
112
65
18.42
137.96
6.5
2.4
ml
2055.0
1881.9
0.64
112
54
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
168
190
9.73
137.86
1.5
1.5
u/ml
122.5
111.2
0.24
44
30
(3017354) Segmented neutrophils/100 leukocytes in Blood
154
158
10.65
135.68
4.6
3.5
%
60.4
56.1
0.93
112
108
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
118
79
16.01
135.23
3.6
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
118
79
16.01
135.23
3.6
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
118
79
16.01
135.23
3.6
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
118
79
16.01
135.23
3.6
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
621
2324
3.69
134.09
3.1
2.0
s
28.7
30.0
6.12
601
2243
(3023368) Bacteria identified in Blood by Culture
913
4379
3.44
132.06
8.4
4.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
114
76
16.04
130.90
2.7
2.0
e6/l
332.7
746.4
3.65
43
38
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
84
27
32.73
129.83
2.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
123
97
13.62
128.50
3.5
2.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
377
1031
4.45
126.43
9.3
4.1
%
0.2
0.4
0.26
257
285
(3020779) Urea [Moles/volume] in Serum or Plasma
441
1393
3.96
120.95
10.4
6.8
mmol/l
12.3
10.6
3.84
425
1317
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
117
95
13.18
120.02
1.7
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1231
7356
3.67
119.25
36.3
6.6
mmol/l
1.2
1.2
0.03
1076
6171
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
247
500
5.64
118.48
1.7
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1122
6385
3.38
116.71
14.2
4.7
g/l
33.2
34.7
13.86
1078
5902
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
143
163
9.51
116.33
4.2
2.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1252
7623
3.68
116.29
42.2
8.7
e9/l
3.1
4.3
73.93
1182
6596
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
157
207
8.28
113.65
1.7
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
148
183
8.79
112.92
5.0
4.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
140
176
8.60
105.28
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
169
264
7.02
105.11
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
107
93
12.24
105.06
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
100
78
13.59
104.93
1.3
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
854
4344
3.01
104.34
26.1
3.8
ph
7.4
7.4
0.15
200
813
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
112
106
11.26
103.98
1.1
1.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1130
6741
3.16
102.63
28.5
5.8
mmol/l
1.2
1.2
0.86
1099
6041
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1193
7341
3.27
102.55
19.6
6.2
umol/l
10.2
12.0
9.75
1178
6944
(3048929) Epstein Barr virus Ab [Presence] in Serum
166
268
6.78
99.97
1.7
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
527
2083
3.25
99.82
3.5
2.5
%
24.1
21.9
3.01
463
1767
(3004789) Transferrin [Mass/volume] in Serum or Plasma
544
2194
3.21
99.54
3.4
2.5
g/l
2.1
2.3
10.27
520
2019
(3044927) Protein electrophoresis panel - Urine
138
185
8.05
98.27
1.7
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
103
94
11.62
97.91
1.2
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
66
26
26.40
95.13
1.7
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
475
1810
3.28
95.07
2.5
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
128
164
8.38
94.63
1.2
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
109
114
10.17
94.27
3.0
1.8
e9/l
1.1
1.0
0.37
58
65
(3022948) Iron [Moles/volume] in Serum or Plasma
558
2375
3.04
91.85
3.4
2.5
umol/l
12.7
12.3
0.74
535
2186
(44790047)
124
160
8.30
91.09
1.8
1.5
—
—
—
0
0
(44790049)
124
160
8.30
91.09
1.8
1.5
—
—
—
0
0
(44790048)
124
160
8.30
91.09
1.8
1.5
—
—
—
0
0
(44806118)
124
160
8.30
91.09
1.8
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
467
1809
3.21
90.38
2.6
1.8
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
81
59
14.39
88.27
2.3
4.9
—
49.1
—
0
10
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
135
210
6.91
83.97
1.8
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
569
2584
2.84
81.55
16.6
4.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
140
250
6.03
75.91
1.7
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
167
351
5.18
75.82
3.6
2.3
g/l
3.7
3.6
0.54
162
330
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
85
86
10.37
75.12
1.6
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
85
86
10.37
75.12
1.6
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
82
83
10.35
72.42
3.4
4.0
—
—
—
0
0
(4035726)
340
1239
3.20
71.35
1.5
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
850
4942
2.49
70.92
8.7
3.3
mmol/l
2.3
2.3
4.32
774
4210
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
111
169
6.97
70.29
1.8
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
326
1170
3.23
70.10
4.4
3.8
ng/l
96.8
96.9
0.01
292
1002
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
237
695
3.82
69.81
2.5
1.8
ug/l
2.3
2.4
0.03
216
602
(1175426) CD3 cells/100 lymphocytes in Blood
79
84
9.83
67.31
2.4
1.8
%
71.4
71.6
0.03
73
78
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
78
82
9.94
67.00
2.3
1.8
%
22.0
14.4
1.27
20
38
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
123
221
5.93
66.13
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
77
81
9.92
66.11
2.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
77
81
9.92
66.11
2.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
85
102
8.73
66.02
2.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
84
102
8.62
64.62
2.2
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
114
196
6.17
64.10
1.6
1.2
u/ml
233.4
298.4
0.82
66
110
(3044640) Blood type and Crossmatch panel - Blood
769
4484
2.34
60.97
7.5
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
111
196
6.00
60.71
1.6
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
187
525
3.89
58.27
2.6
3.2
g/l
0.6
0.3
3.62
114
209
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
72
82
9.14
58.20
3.5
2.0
e6/l
644.0
558.3
0.27
61
71
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
71
81
9.12
57.31
2.2
1.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
53
40
13.66
56.39
2.2
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
77
101
7.95
55.54
1.2
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
107
204
5.54
53.90
5.5
6.1
mg/l
10.5
12.2
2.88
98
188
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
68
80
8.82
53.57
3.7
2.0
e9/l
0.3
0.2
0.48
60
71
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
108
209
5.46
53.52
1.5
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
66
75
9.13
53.41
3.0
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
843
5347
2.18
51.77
4.0
2.8
ug/l
322.8
154.9
12.74
794
4817
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
959
6398
2.20
51.77
10.7
4.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
40
21
19.50
51.11
1.9
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1157
8357
2.29
50.76
14.8
4.8
mmol/l
6.6
6.9
4.43
1126
7871
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
61
68
9.28
50.07
1.2
1.3
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
34
13
26.68
49.15
2.0
1.2
—
875.7
—
0
5
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
182
564
3.50
48.74
3.2
2.8
u/ml
0.3
0.4
0.83
110
330
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
656
3848
2.17
48.28
2.3
2.2
mg/l
3.0
3.1
0.57
563
3240
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
606
3455
2.19
47.85
6.7
2.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
347
1556
2.56
47.71
7.7
2.7
umol/l
7.1
9.6
1.06
315
1362
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
127
310
4.36
47.66
2.3
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
91
170
5.61
46.80
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
97
193
5.28
46.55
2.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
97
193
5.28
46.55
2.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
98
197
5.23
46.49
2.6
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
97
195
5.22
46.01
2.6
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
197
666
3.22
45.81
4.6
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
97
196
5.20
45.75
2.6
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
240
911
2.91
45.59
1.7
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
96
195
5.17
45.00
2.6
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
767
4899
2.06
43.91
4.9
3.1
ng/l
1928.1
1712.9
0.67
703
4242
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
73
119
6.37
43.15
1.5
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
44
38
11.87
43.06
4.2
1.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
42
34
12.65
42.78
1.9
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
569
3321
2.09
40.95
26.8
6.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
800
5283
2.00
40.75
4.4
3.5
—
—
—
0
0
(4062490)
65
101
6.66
40.23
1.4
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
244
997
2.70
40.04
5.4
4.0
mmol/l
0.9
2.0
3.92
177
742
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
109
271
4.24
39.85
8.3
3.3
%
48.9
59.8
8.86
109
271
(3028192) IgG subclass 2 [Mass/volume] in Serum
64
99
6.69
39.77
1.4
1.3
g/l
1.5
2.8
3.20
41
67
(3024139) IgG subclass 3 [Mass/volume] in Serum
64
99
6.69
39.77
1.4
1.3
g/l
0.2
0.5
3.47
41
67
(3027135) IgG subclass 1 [Mass/volume] in Serum
64
99
6.69
39.77
1.4
1.3
g/l
11.1
7.4
1.40
43
67
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
497
2800
2.11
38.95
2.5
1.6
mg/l
1.5
1.4
0.26
410
2186
(3030905) Polymorphonuclear cells [#/volume] in Blood
105
259
4.26
38.78
6.8
3.0
e9/l
2.9
4.5
12.37
105
259
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
29
14
21.07
38.25
1.4
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
29
14
21.07
38.25
1.4
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
29
14
21.07
38.25
1.4
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
29
14
21.07
38.25
1.4
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
247
1042
2.61
37.92
5.5
4.0
ph
7.4
7.4
1.69
39
129
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
244
1024
2.62
37.85
2.4
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
249
1056
2.60
37.81
5.5
4.0
kpa
4.8
5.2
8.58
229
975
(3033658) Prothrombin time (PT) actual/Normal
583
3519
2.02
37.59
7.3
4.0
%
87.4
85.2
1.21
571
3424
(3002032) Base excess in Venous blood by calculation
314
1489
2.37
37.43
7.0
3.6
mmol/l
1.5
2.0
1.27
248
1179
(3002582) Erythrocytes [#/volume] in Urine
692
4445
1.96
37.20
4.4
3.5
e6/l
38.6
88.8
1.53
591
3508
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
31
19
16.61
36.70
1.4
1.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
313
1496
2.35
36.57
7.0
3.5
kpa
5.7
5.8
1.90
308
1448
(3036489) Thrombin time
141
452
3.32
35.55
3.7
1.9
s
22.4
21.8
0.62
135
404
(3036481) Cortisol [Moles/volume] in Serum or Plasma
262
1172
2.47
35.42
2.2
2.2
nmol/l
388.7
369.7
0.71
250
1057
(3030467) Casts [#/volume] in Urine by Automated count
643
4091
1.94
35.02
4.3
3.4
e6/l
0.5
0.5
0.10
543
3157
(3012544) pH of Venous blood
314
1542
2.28
34.25
7.0
3.6
ph
7.4
7.4
—
6
7
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
120
357
3.55
33.98
3.9
3.5
mg/l
1.8
1.8
0.21
109
318
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
264
1219
2.39
33.14
20.6
3.8
mmol/l
1.2
1.2
1.66
258
1043
(3000991) Gas panel - Venous blood
277
1307
2.35
33.10
9.3
7.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
818
5721
1.85
32.47
29.8
10.3
e9/l
0.0
0.0
0.70
721
4647
(4212803)
27
16
17.14
32.44
1.0
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
742
5041
1.86
32.26
5.0
4.0
e6/l
105.8
121.7
0.18
611
3741
(36304419) Bacteria [Presence] in Urine
610
3909
1.89
31.76
4.2
3.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
64
124
5.33
31.59
1.9
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
878
6326
1.83
31.18
12.0
10.9
inr
1.3
1.3
0.14
238
1729
(3024980) IgG subclass 4 [Mass/volume] in Serum
75
169
4.60
31.05
1.5
1.7
g/l
0.3
0.9
3.68
50
126
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
162
611
2.83
30.72
3.0
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
683
4594
1.83
30.06
3.6
3.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
514
3163
1.91
29.97
3.3
2.7
e6/l
5.7
4.8
0.94
475
2782
(3021960) Folate [Moles/volume] in Serum or Plasma
578
3728
1.85
28.87
2.0
1.6
nmol/l
18.9
20.2
1.26
540
3116
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
164
648
2.70
28.40
6.4
4.3
mmol/l
24.1
24.9
2.80
152
603
(3026782) Osmolality of Urine
489
3004
1.89
28.39
3.7
2.9
mosm/kgh2o
526.7
553.7
2.53
450
2558
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
40
56
7.30
27.20
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
503
3157
1.85
27.07
2.0
1.8
nmol/l
1148.8
1164.8
0.13
409
2341
(3000093) Morphology [Interpretation] in Blood Narrative
65
146
4.59
27.02
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
106
339
3.27
26.75
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
106
339
3.27
26.75
1.5
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1272
10513
1.92
26.72
30.8
7.7
u/l
78.1
80.6
1.09
1255
9821
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
174
738
2.52
26.03
7.8
3.7
mmol/l
23.9
24.0
0.24
160
666
(3024471) HLA-A [Type]
30
32
9.53
25.34
1.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
47
85
5.66
24.99
1.9
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
302
1645
2.02
24.56
1.9
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
115
410
2.94
24.09
1.9
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
360
2100
1.91
23.93
2.0
2.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
103
347
3.10
23.83
1.9
1.5
g/l
1.1
1.2
0.96
96
333
(3022313) Gas panel - Capillary blood
174
769
2.41
23.76
6.1
4.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1104
12848
0.57
23.15
4.6
5.4
mmol/l
2.5
2.6
2.16
1010
11539
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
99
332
3.11
23.08
1.8
1.5
g/l
0.2
0.2
0.09
89
317
(3024932) HLA-DR beta [Type]
28
31
9.17
23.00
1.5
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
50
105
4.88
22.54
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
63
160
4.05
22.37
1.2
1.3
miu/ml
215.4
206.4
0.05
21
56
(3025941) Bacteria identified in Stool by Culture
153
658
2.46
22.14
1.3
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
18
10
18.19
22.11
1.1
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
100
346
3.01
22.09
4.1
4.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
453
2909
1.77
21.79
5.7
3.0
mmol/l
2.5
2.5
3.41
411
2548
(40765096) Chromosome analysis panel by Banding
34
51
6.79
21.72
1.3
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
31
42
7.50
21.67
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
52
119
4.48
21.14
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
492
3260
1.73
21.07
1.6
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
402
2533
1.78
20.46
3.6
2.9
e6/l
1.1
1.2
0.24
252
1499
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
103
4.67
20.15
1.7
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
381
2388
1.77
19.64
3.8
3.2
e6/l
2.3
1.9
0.45
230
1367
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
734
5477
1.61
19.43
2.7
2.2
nmol/l
81.4
79.1
1.26
683
4753
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
766
5775
1.61
19.43
5.6
4.1
ng/l
40.1
58.4
1.29
667
4423
(3001964) Herpes simplex virus Ag [Presence] in Specimen
28
39
7.29
19.10
1.1
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
246
1358
1.95
18.92
6.6
6.6
mmol/l
1.2
1.4
2.54
239
1306
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
41
85
4.92
18.77
1.8
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
26
34
7.75
18.71
3.2
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
26
34
7.75
18.71
1.2
1.1
miu/ml
1006.4
1705.3
1.54
26
34
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
813
6262
1.59
18.53
2.5
2.1
pmol/l
90.6
93.8
1.22
563
3236
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1087
12522
0.61
18.47
4.3
4.8
mmol/l
4.3
4.5
3.52
1000
11298
(3031040) Bacteria [#/volume] in Urine by Automated count
1099
9095
1.63
18.46
6.2
5.0
e6/l
478.8
2041.1
1.22
18
152
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
306
1829
1.83
18.37
7.0
6.8
kpa
4.9
5.1
2.93
287
1736
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
69
214
3.32
18.31
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1104
12659
0.61
18.18
5.5
5.1
mmol/l
6.1
6.1
0.23
994
11252
(3016502) Oxygen saturation in Arterial blood
281
1643
1.86
18.09
7.2
7.1
%
95.0
95.4
0.35
266
1577
(3027801) Oxygen [Partial pressure] in Arterial blood
305
1830
1.82
18.06
7.0
6.8
kpa
11.7
11.9
0.29
286
1740
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1076
12400
0.62
17.88
4.2
4.7
mmol/l
1.3
1.4
10.85
983
11098
(3003396) Base excess in Arterial blood by calculation
305
1836
1.81
17.85
6.9
6.8
mmol/l
0.7
1.1
0.80
229
1414
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
40
85
4.80
17.80
1.8
1.6
—
—
—
0
0
(3019225) pH of Specimen
269
1561
1.86
17.71
25.5
4.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
86
312
2.85
17.46
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
801
6226
1.56
17.01
3.3
2.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1056
12178
0.63
16.89
6.3
6.5
mmol/mol
40.8
40.9
0.04
971
11036
(3003740) Influenza virus B Ag [Presence] in Specimen
44
108
4.16
16.39
1.3
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
255
1494
1.84
16.19
7.8
7.4
g/l
106.5
121.0
24.36
246
1437
(3002523) Influenza virus A Ag [Presence] in Specimen
44
109
4.12
16.19
1.3
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
118
520
2.37
16.14
1.4
1.9
u/l
35.1
38.0
0.66
109
449
(3037522) Nuclear Ab [Titer] in Serum
255
1501
1.83
15.93
1.3
1.3
titre
649.2
528.4
0.24
26
344
(3037692) Legionella sp identified in Specimen by Organism specific culture
29
51
5.77
15.89
1.1
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
32
62
5.24
15.83
2.0
2.3
u/ml
2344.3
1576.1
0.24
32
62
(3013707) Erythrocyte sedimentation rate by Westergren method
1158
9863
1.59
15.77
8.5
4.2
mm/h
33.3
14.1
70.54
1108
9009
(40768446) Kidney Pathology biopsy report
27
45
6.08
15.61
1.1
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
87
339
2.65
15.43
3.1
2.6
%
14.7
16.0
2.01
47
177
(3024354) Oxygen [Partial pressure] in Venous blood
219
1243
1.88
15.34
5.7
2.9
kpa
4.7
4.5
0.47
214
1201
(3010421) pH of Blood
100
419
2.48
15.28
4.4
4.7
ph
7.4
7.4
1.17
85
342
(3037467) Urinalysis macro (dipstick) panel - Urine
1100
9314
1.55
14.87
5.8
4.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
45
5.85
14.48
1.5
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
586
4366
1.53
14.37
2.9
2.5
u/l
57.1
58.0
0.19
555
3996
(3012501) Base excess in Blood by calculation
86
347
2.56
14.23
4.3
5.1
mmol/l
2.5
2.7
0.30
63
246
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
63
217
2.98
14.08
1.1
1.4
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
25
43
5.89
14.01
2.5
2.2
%
5.4
9.9
0.88
19
38
(3028626) Oxygen [Partial pressure] in Capillary blood
91
383
2.46
13.78
3.2
3.3
kpa
8.6
7.9
3.85
83
347
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
550
4078
1.52
13.63
6.1
3.2
u/l
35.7
36.3
0.07
529
3856
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
120
575
2.17
13.45
2.7
2.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
422
2967
1.57
13.25
6.0
4.0
ng/l
140.8
344.6
2.84
370
2535
(3052592) Norovirus Ag [Presence] in Stool
21
33
6.43
12.84
1.5
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
17
21
8.17
12.77
1.4
2.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
14
10.08
12.24
1.5
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
14
14
10.08
12.24
1.5
1.1
%
95.9
89.4
0.21
14
14
(3017732) Neutrophils [#/volume] in Blood
158
868
1.91
12.16
4.5
3.3
e9/l
3.4
4.2
2.76
120
637
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
45
140
3.28
11.95
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
66
4.45
11.93
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
28
62
4.58
11.91
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
249
1577
1.68
11.85
2.2
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
28
63
4.50
11.68
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
28
63
4.50
11.68
1.0
1.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
173
992
1.83
11.64
5.8
3.0
g/l
108.8
127.0
20.01
167
966
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
16
21
7.68
11.43
1.8
1.6
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
20
34
5.94
11.34
1.6
1.4
titre
112.4
139.8
—
5
8
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1068
12002
0.69
11.30
4.3
4.2
mmol/l
1.4
1.3
2.15
977
10641
(3021901) Oxygen saturation in Capillary blood
75
318
2.42
11.22
3.2
3.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
93
439
2.19
10.85
3.4
3.4
mmol/l
23.7
25.2
2.36
80
377
(3007930) Methemoglobin/Hemoglobin.total in Blood
123
646
1.98
10.81
7.5
4.9
%
0.9
0.9
0.01
116
605
(3000060) B lymphocytes [#/volume] in Blood
17
26
6.60
10.64
2.6
2.1
e6/l
78.9
161.4
—
9
7
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
235
3497
0.62
10.48
1.6
1.6
mmol/l
1.7
1.3
1.83
215
2862
(3032352) Blasts [#/volume] in Cerebral spinal fluid
12
12
10.07
10.45
1.7
2.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
148
836
1.85
10.44
8.9
9.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
123
654
1.95
10.43
7.6
4.8
%
1.6
1.6
0.24
116
612
(3006184) Hemoglobin [Mass/volume] in Capillary blood
77
348
2.27
9.99
3.0
2.2
g/l
115.9
128.9
4.35
58
258
(40768795) Lymph node Pathology biopsy report
39
125
3.17
9.91
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
779
6454
1.39
9.76
4.3
4.0
estimate
0.0
0.0
0.00
178
1212
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
13
16
8.18
9.74
11.7
11.1
mmol/l
4.9
5.7
0.47
13
16
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
61
252
2.48
9.68
3.8
3.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
91
447
2.10
9.62
4.6
3.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
144
838
1.79
9.22
7.5
8.9
mmol/l
23.7
24.4
1.15
130
781
(3009261) Glucose [Presence] in Urine by Test strip
784
6544
1.38
9.19
4.4
4.0
estimate
0.0
0.0
0.80
170
1185
(3021601) Nitrite [Presence] in Urine by Test strip
775
6457
1.38
9.19
5.9
5.4
estimate
0.0
0.0
0.00
175
1217
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
24
58
4.18
9.19
10.2
3.3
u/l
200.5
216.1
0.67
24
58
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
19
38
5.05
9.10
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
97
3.34
8.91
1.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
176
1095
1.68
8.88
5.6
4.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
26
69
3.81
8.80
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
44
163
2.75
8.71
1.5
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
17
32
5.36
8.69
1.6
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
10
10
10.06
8.65
2.0
4.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
26
5.81
8.33
1.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
33
107
3.13
8.27
1.6
1.4
—
30.4
—
0
9
(3028679) Herpes simplex virus Ab [Presence] in Serum
20
46
4.39
8.15
1.1
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
104
569
1.88
8.13
2.8
2.2
ug/l
602.1
532.3
0.09
98
532
(1761868) Lipid panel - Serum or Plasma
271
3730
0.67
8.04
2.9
3.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
24
5.87
7.86
1.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
25
5.64
7.55
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
233
1615
1.52
7.44
5.4
3.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
124
740
1.73
7.30
4.7
2.5
%
0.7
0.7
0.07
118
716
(3030981) Hyaline casts [#/volume] in Urine by Automated count
131
795
1.70
7.26
3.1
2.9
e6/l
0.3
0.3
0.05
131
781
(3003434) Protein [Mass/volume] in Pleural fluid
55
248
2.26
7.25
1.4
1.5
g/l
30.4
31.2
0.13
49
222
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
54
242
2.27
7.23
1.3
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
10
13
7.73
7.12
1.2
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
158
1013
1.62
7.09
7.8
6.3
mmol/l
24.0
24.5
0.75
147
947
(3011397) Hemoglobin [Presence] in Urine by Test strip
404
3132
1.38
7.06
4.0
3.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
47
203
2.35
6.86
3.8
3.5
u/ml
100.4
32.3
0.70
47
198
(3047181) Lactate [Moles/volume] in Blood
89
491
1.86
6.82
7.9
5.9
mmol/l
1.2
1.3
0.97
79
427
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
68
344
2.02
6.72
1.2
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
233
1656
1.47
6.56
2.8
4.0
ug/l
5.6
21.1
2.18
186
1377
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
210
1464
1.50
6.50
4.0
3.0
ng/l
287.2
230.6
0.89
191
1345
(3023183) Ammonium ion [Moles/volume] in Plasma
66
336
2.00
6.42
2.0
2.7
umol/l
28.2
33.8
1.63
48
277
(3032057) Clostridioides difficile [Presence] in Stool
17
43
3.98
6.17
2.0
1.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1320
13968
0.72
6.11
76.9
25.1
g/l
117.8
133.3
180.04
1302
13693
(3010813) Leukocytes [#/volume] in Blood
1320
13967
0.72
6.10
76.6
24.9
e9/l
6.4
6.9
2.49
1294
13479
(3026361) Erythrocytes [#/volume] in Blood
1320
13965
0.72
6.07
76.5
24.9
e12/l
3.8
4.4
190.91
1294
13483
(3035941) MCH [Entitic mass]
1320
13964
0.72
6.05
76.2
24.8
pg
31.4
30.4
57.14
1303
13690
(3024731) MCV [Entitic volume]
1320
13963
0.72
6.03
76.3
24.8
fl
95.2
91.7
95.35
1302
13691
(3007461) Platelets [#/volume] in Blood
1320
13963
0.72
6.03
76.6
24.9
e9/l
196.9
241.6
77.56
1294
13527
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
35
141
2.51
5.96
1.3
1.2
u/l
56.6
50.1
0.44
30
96
(3014765) Yersinia sp identified in Stool by Organism specific culture
70
374
1.91
5.95
1.2
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
49
3.70
5.92
1.7
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
70
377
1.89
5.82
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
69
371
1.90
5.77
1.2
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
28
103
2.75
5.70
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
61
318
1.95
5.59
1.5
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
25
88
2.87
5.52
4.7
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
163
1118
1.51
5.46
5.3
2.9
ml/min/173m2
51.6
61.0
2.94
98
466
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
5
16.07
5.41
1.8
3.6
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
8
5
16.07
5.41
1.4
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
9
8
11.30
5.29
3.3
4.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
103
640
1.65
5.28
3.9
3.3
pmol/l
4.4
4.4
0.09
97
545
(3023199) Leukocytes [#/volume] in Pleural fluid
47
228
2.09
5.26
1.4
1.4
e6/l
941.5
1662.6
1.92
34
167
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
31
127
2.47
5.14
1.4
1.2
u/l
11.3
12.3
0.15
26
119
(3018572) Chloride [Moles/volume] in Blood
65
357
1.85
5.12
9.6
6.4
mmol/l
105.5
105.3
0.09
58
319
(3039000) Anion gap in Blood
65
357
1.85
5.12
9.6
6.4
mmol/l
11.4
11.2
0.24
58
319
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
75
435
1.76
4.96
1.8
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
16
47
3.43
4.75
1.1
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
67
381
1.79
4.75
1.4
1.6
iu/ml
0.2
17.1
0.56
16
79
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
20
68
2.97
4.72
1.3
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
37
171
2.19
4.70
2.8
3.9
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
22
80
2.77
4.62
1.4
1.2
u/l
45.1
21.0
1.16
22
68
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
74
1205
0.60
4.60
1.5
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
38
180
2.14
4.56
1.4
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
93
590
1.61
4.43
2.4
3.3
u/ml
660.8
8140.7
0.90
76
502
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
33
151
2.21
4.32
1.1
1.1
—
15.8
—
0
7
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
6
11.71
4.27
1.4
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
69
409
1.72
4.27
1.4
1.5
ug/g
224.0
273.5
1.27
41
247
(3048689) Calprotectin [Mass/mass] in Stool
175
1281
1.41
4.21
2.2
2.2
ug/g
171.5
160.9
0.09
144
1006
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
524
4477
1.25
4.16
2.4
2.2
u/l
158.5
229.9
1.93
496
4170
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
22
85
2.61
4.14
1.4
1.2
u/l
129.5
89.5
0.70
22
74
(3023419) Bacteria identified in Sputum by Culture
39
200
1.97
3.84
2.3
2.7
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
6
5
12.04
3.76
1.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
37
188
1.99
3.74
5.8
6.2
mmol/l
7.2
7.6
0.23
28
161
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1098
11705
0.81
3.69
4.9
4.7
mu/l
2.1
2.1
0.00
1023
10436
(40757373) Influenza virus identified in Isolate
13
40
3.27
3.63
1.2
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
51
293
1.76
3.57
1.3
1.4
mmol/l
52.8
63.5
1.70
41
240
(3025315) Body weight
7
9
7.80
3.56
5.1
4.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
9
7.80
3.56
1.4
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
9
7.80
3.56
1.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
13
6.18
3.50
1.3
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
12
36
3.35
3.48
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
69
2.63
3.47
1.1
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
39
208
1.90
3.46
1.4
1.4
e6/l
77936.3
91521.2
0.10
22
127
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1296
13550
0.80
3.46
38.2
11.3
u/l
26.2
25.4
0.70
1277
12962
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
115
810
1.45
3.45
2.7
2.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
47
267
1.78
3.42
1.2
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
37
195
1.92
3.40
1.4
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
179
1364
1.35
3.40
1.4
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
24
497
0.48
3.39
1.2
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
172
1305
1.36
3.36
2.8
2.4
u/l
47.6
39.9
0.33
142
1098
(3004716) Salmonella sp identified in Stool by Organism specific culture
76
495
1.56
3.32
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
65
2.63
3.30
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
19
77
2.48
3.30
1.3
1.6
umol/l
16.8
15.1
0.31
19
72
(40761536) Microorganisms panel - Urine sediment
152
1137
1.37
3.25
5.2
4.3
—
—
—
0
0
(3020891) Body temperature
93
637
1.49
3.23
5.2
4.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
41
228
1.82
3.22
2.5
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
164
1247
1.35
3.17
4.1
3.6
—
—
—
0
0
(3004451) EKG impression Narrative
20
85
2.37
3.15
1.4
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
57
352
1.64
3.11
7.3
3.4
mmol/l
7.3
7.8
0.70
57
344
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
40
3.01
2.97
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
110
794
1.41
2.93
4.4
3.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
292
0.37
2.91
1.4
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
55
343
1.62
2.91
5.4
2.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
28
143
1.97
2.85
1.1
1.2
u/ml
3.3
6.5
—
10
71
(3014271) Vancomycin [Susceptibility]
21
96
2.20
2.84
3.4
3.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
35
194
1.82
2.81
1.5
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
30
158
1.92
2.81
4.5
3.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
23
3.93
2.77
1.0
1.1
—
—
—
0
0
(3013512) EKG study
503
4439
1.19
2.70
5.2
4.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
86
2.22
2.64
2.0
1.6
u/l
4.3
9.0
0.73
13
41
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
20
399
0.50
2.60
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
277
3285
0.81
2.59
2.9
3.2
ug/l
1.0
0.8
1.25
205
2309
(40761511) CBC panel - Blood by Automated count
1259
13111
0.83
2.56
41.7
16.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
408
0.51
2.53
1.2
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
50
2.61
2.53
4.2
2.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
955
10167
0.86
2.50
67.8
22.5
g/l
329.6
331.6
9.71
948
10067
(3029937) Albumin [Presence] in Urine by Test strip
411
3585
1.20
2.49
4.9
4.3
estimate
0.0
0.0
0.50
143
1160
(3033705) Calcium.ionized [Moles/volume] in Venous blood
37
218
1.71
2.46
4.9
2.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
24
442
0.54
2.45
1.7
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
27
145
1.88
2.42
1.1
1.2
u/ml
1.6
4.0
—
9
46
(3021788) Differential panel - Synovial fluid
45
281
1.62
2.41
1.6
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
385
3352
1.19
2.37
4.3
3.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
42
259
1.64
2.37
1.3
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1313
13599
0.83
2.37
59.7
20.3
mmol/l
4.0
4.0
1.31
1296
13211
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
22
3.65
2.36
1.3
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
17
4.13
2.36
1.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1156
12100
0.85
2.34
46.0
16.1
ml/min/173m2
68.0
73.9
12.80
1045
10013
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
549
4931
1.17
2.33
4.9
4.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
65
2.32
2.31
6.9
6.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
63
431
1.48
2.28
4.7
4.9
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
23
3.49
2.27
1.0
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
9
5.57
2.21
1.2
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1312
13570
0.84
2.20
55.0
20.1
mmol/l
138.9
139.6
21.62
1295
13198
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
176
1426
1.26
2.18
2.4
2.2
g/l
0.2
0.2
1.07
165
1320
(3006270) Folate [Moles/volume] in Blood
23
122
1.90
2.16
1.3
1.2
nmol/l
346.1
354.4
0.06
17
103
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
94
1246
0.74
2.16
1.3
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
30
3.01
2.15
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
265
2252
1.21
2.12
25.1
29.2
inr
1.3
1.4
0.37
33
301
(3045414) Leukocytes [Presence] in Urine
82
599
1.39
2.11
2.1
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
35
213
1.66
2.11
1.6
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
57
392
1.47
2.04
1.2
1.2
u/ml
0.3
0.8
—
5
30
(4146454)
7
179
0.39
2.02
1.3
2.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
610
0.65
2.01
1.6
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
11
45
2.45
1.93
4.5
2.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
39
2.57
1.92
1.2
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
58
2.25
1.91
1.0
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
176
1456
1.23
1.84
2.9
2.5
ug/l
5.3
6.9
0.72
152
1261
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
40
2.51
1.83
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
40
2.51
1.83
1.2
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
12
4.18
1.82
1.2
1.0
—
—
—
0
0
(3000492) Spirometry study
80
1056
0.75
1.82
1.6
1.5
—
—
—
0
0
(4027681)
12
53
2.27
1.81
1.4
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
17
88
1.94
1.75
1.8
2.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
30
2.67
1.72
1.9
2.1
mmol/l
1.2
1.2
—
8
30
(4010399)
78
1022
0.75
1.70
1.5
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
75
2.01
1.69
3.8
3.9
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
15
75
2.01
1.69
1.7
1.5
u/field
0.9
3.3
—
10
53
(3008295) Osmolality of Serum or Plasma
26
156
1.68
1.69
1.5
1.3
mosm/kgh2o
278.9
275.2
0.22
20
111
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
42
2.39
1.68
1.2
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
25
2.81
1.65
1.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
25
2.81
1.65
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
145
0.41
1.64
3.0
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
573
5272
1.13
1.64
2.4
2.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
66
488
1.37
1.64
4.2
3.6
mmol/l
3.9
3.9
0.06
61
449
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
69
514
1.36
1.63
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
205
1746
1.20
1.63
1.4
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
52
370
1.42
1.61
1.8
1.7
e6/l
20119.2
14631.5
0.57
38
270
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
43
2.33
1.60
1.2
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
20
3.01
1.58
1.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
15
3.34
1.52
1.4
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
419
4608
0.88
1.52
4.1
4.6
%
21.8
21.9
0.03
216
2393
(36660697) Celiac disease serology panel - Serum
107
858
1.26
1.51
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
25
154
1.63
1.50
1.3
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
116
1.73
1.49
1.6
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
65
2.01
1.48
1.7
1.9
u/l
237.7
4519.8
—
7
20
(3017569) Oxygen content in Arterial blood
15
80
1.88
1.45
3.1
2.7
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
5
16
3.13
1.44
1.4
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
16
3.13
1.44
1.4
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
17
95
1.80
1.43
3.0
3.1
ph
7.4
7.4
—
8
30
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
275
2433
1.16
1.40
1.3
1.2
u/ml
1.0
1.5
0.78
34
619
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
27
174
1.56
1.37
1.4
1.6
%
69.6
62.2
0.51
19
118
(3013139) Helicobacter pylori Ag [Presence] in Stool
61
796
0.76
1.34
1.1
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
43
2.10
1.30
1.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
18
2.78
1.28
1.2
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
138
1.60
1.26
1.3
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
489
4522
1.12
1.24
8.0
3.3
mg/l
8390.0
237.3
20.88
386
2870
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
6
25
2.41
1.24
1.2
1.8
%
—
5.1
—
0
12
(3036048) Francisella tularensis Ab [Titer] in Serum
6
25
2.41
1.24
1.2
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
36
2.23
1.24
1.3
1.8
ug/l
44.5
249.4
—
8
30
(3032773) Endomysium IgG Ab [Titer] in Serum
15
85
1.77
1.23
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
54
408
1.33
1.23
1.4
1.4
—
—
—
0
0
(4281824)
7
144
0.48
1.20
1.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
101
1.69
1.20
1.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1315
12821
1.13
1.18
58.7
16.9
mg/l
21.3
26.9
10.05
1258
10447
(3044941) Cell count panel - Synovial fluid
35
248
1.42
1.17
1.5
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
33
0.00
1.16
0.0
6.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
19
118
1.62
1.15
1.3
1.3
—
—
—
0
0
(4094501)
24
355
0.67
1.14
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
37
267
1.39
1.13
1.5
1.3
e6/l
10.9
42.7
0.77
29
211
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
37
267
1.39
1.13
1.6
1.4
e6/l
23.5
645.4
0.91
28
221
(3020961) Endomysium IgA Ab [Titer] in Serum
61
477
1.29
1.11
1.1
1.1
titre
—
193.7
—
0
11
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
128
1.57
1.08
1.9
2.1
u/field
0.5
1.9
—
8
42
(3020682) Albumin/Creatinine [Ratio] in Urine
446
4795
0.90
1.06
4.2
4.0
mg/mmol
21.7
8.8
3.75
335
3010
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
113
1.60
1.05
1.2
1.1
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
7
33
2.13
1.05
1.1
3.1
ml/dl
13.8
15.0
—
7
28
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
49
375
1.32
1.05
1.6
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
124
0.48
1.05
1.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
124
0.48
1.05
1.0
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
67
1.80
1.04
1.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
125
0.48
1.04
1.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
125
0.48
1.04
1.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
130
1.55
1.02
1.4
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
53
412
1.30
1.02
2.7
3.3
nmol/l
0.8
0.8
0.40
36
320
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
48
1.88
1.00
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
429
4609
0.91
1.00
3.4
3.2
mmol/l
7.0
7.3
0.56
373
3781
(3010144) Erythrocytes [#/volume] in Synovial fluid
21
140
1.51
0.97
1.5
1.4
e6/l
18347.1
82015.6
0.72
13
98
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
54
1.86
0.96
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
149
1.48
0.95
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
74
608
1.23
0.93
1.5
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
167
1.44
0.92
1.6
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
28
2.15
0.91
1.2
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
28
204
1.38
0.85
2.4
2.3
u/ml
121.9
217.5
0.18
28
199
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
12
72
1.67
0.85
1.8
1.9
nmol/l
20.7
17.6
0.41
12
65
(3042733) HLA Ab [Presence] in Serum
6
31
1.94
0.84
2.7
4.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
111
958
1.17
0.84
2.4
2.1
nmol/l
11.6
12.7
0.61
94
825
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
10
57
1.76
0.83
1.3
1.1
u/l
1.0
1.2
—
5
33
(3016879) Cocaine [Presence] in Urine
6
115
0.52
0.82
1.0
1.5
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
11
65
1.70
0.82
1.2
1.5
—
11.7
—
0
5
(4268621)
16
105
1.53
0.81
2.1
2.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
97
1.55
0.81
9.1
15.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
89
1.58
0.81
2.4
2.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
43
340
1.27
0.78
2.5
2.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
18
123
1.47
0.77
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
25
336
0.74
0.75
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
53
1.70
0.75
1.3
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
43
342
1.26
0.75
1.8
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
210
1.34
0.74
1.9
1.3
u/l
12.3
9.5
0.44
21
162
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
98
1126
0.86
0.72
1.7
1.7
%
1.4
1.6
2.10
81
933
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
39
1.80
0.72
1.1
2.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
183
0.65
0.72
1.8
1.4
—
—
—
0
0
(4306422)
19
134
1.42
0.71
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
134
1.42
0.71
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
19
135
1.41
0.69
1.3
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
94
0.53
0.66
1.0
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
75
643
1.17
0.65
1.4
1.2
u/ml
82.1
184.9
2.96
68
585
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
35
278
1.26
0.64
1.4
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
87
1.50
0.63
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
87
1.50
0.63
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
87
1.50
0.63
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
929
9542
0.94
0.62
5.3
4.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
11
71
1.55
0.62
1.5
1.4
%
63.2
65.1
—
6
52
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
43
352
1.23
0.61
1.4
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
206
1896
1.10
0.61
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
88
1.48
0.60
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
88
1.48
0.60
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
88
1.48
0.60
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
162
1475
1.11
0.60
1.4
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
310
2909
1.08
0.59
4.7
4.4
kg/l
1.0
1.0
0.26
53
439
(3002385) Erythrocyte distribution width [Ratio]
1048
10240
1.06
0.59
64.7
20.6
%
15.1
13.9
81.39
1034
9988
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
254
0.75
0.59
1.4
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
123
1.39
0.58
1.8
1.8
%
6.5
11.1
3.70
17
123
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
36
1.67
0.56
2.5
3.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
16
218
0.73
0.56
1.7
1.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
30
239
1.26
0.55
1.4
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
93
1.40
0.48
3.1
2.5
—
—
—
0
0
(4034850)
36
430
0.83
0.47
21.2
11.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
85
1.41
0.47
1.5
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
85
1.41
0.47
1.5
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
218
1.24
0.46
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
69
1.45
0.44
1.0
1.2
nmol/l
150.3
141.8
—
10
69
(3022621) pH of Urine by Test strip
106
964
1.11
0.44
3.0
3.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
148
1.29
0.43
1.3
1.4
pmol/l
375.8
279.5
0.51
14
114
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
32
1.56
0.42
1.2
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
15.7
—
0
16
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
79
1.40
0.40
2.5
2.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
18
0.00
0.40
0.0
1.0
—
7.7
—
0
7
(3004616) Nuclear Ab [Presence] in Serum
13
171
0.76
0.39
1.3
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
36
1.39
0.38
6.6
8.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
279
0.82
0.37
1.2
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
786
7689
1.04
0.36
3.8
3.2
u/l
63.0
54.9
1.42
745
7001
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
157
0.76
0.36
1.2
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
90
1.34
0.35
1.2
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
6
44
1.36
0.34
1.3
1.1
—
16.3
—
0
8
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
557
5719
0.96
0.32
4.7
5.4
ug/l
3.1
4.2
0.67
493
5041
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
7
54
1.30
0.30
1.3
1.1
—
301.1
—
0
14
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
14
174
0.80
0.29
1.3
1.2
nmol/l
0.7
0.6
0.31
14
163
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
29
251
1.16
0.28
1.4
1.7
iu/l
2.3
5.3
3.09
11
80
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
40
1.25
0.22
1.4
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
38
343
1.11
0.22
3.8
3.8
mg/l
24.8
28.6
0.42
25
213
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
3970.3
—
0
6
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
12
98
1.23
0.21
1.6
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
43
1.16
0.21
1.2
1.0
pmol/l
151.8
258.5
—
5
31
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
29.6
—
0
13
(3016330) Potassium [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
6
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
14
0.00
0.20
0.0
1.2
—
0.2
—
0
8
(3009542) Hematocrit [Volume Fraction] of Blood
1104
11141
0.97
0.20
49.9
18.4
%
34.5
38.7
25.98
661
6956
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
53
1.13
0.18
4.8
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
53
1.13
0.18
2.2
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
53
1.13
0.18
2.2
2.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
58
1.21
0.18
2.1
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
100
1.20
0.18
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
11
91
1.21
0.17
1.0
1.4
promille
1.0
1.0
—
6
71
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
183
0.87
0.16
1.1
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
183
1885
0.97
0.15
1.2
1.2
u/ml
4.4
14.8
2.27
42
665
(3005570) Glucose [Moles/volume] in Urine
13
149
0.87
0.13
2.5
2.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
333
3268
1.02
0.13
1.7
1.8
pmol/l
424.4
27757082.2
2.58
277
2630
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
178
1829
0.97
0.13
3.9
4.8
%
32.7
33.1
0.20
131
1170
(4024509)
12
136
0.88
0.11
1.7
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
180
1840
0.98
0.10
13.5
8.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
200
1959
1.02
0.10
1.3
1.2
iu/ml
27.7
39.6
0.52
54
622
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
952
9574
0.99
0.09
4.1
3.9
pmol/l
15.0
15.0
0.47
890
8464
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
318
0.94
0.08
1.4
1.2
u/ml
1.4
8.1
—
6
51
(44813793)
5
64
0.78
0.08
1.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
68
1.03
0.07
2.6
1.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
74
0.81
0.07
4.3
1.5
g/l
1.0
1.0
—
6
74
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
152
0.92
0.06
1.2
1.2
nmol/l
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
65
633
1.03
0.05
1.1
1.2
iu/ml
106.2
141.1
0.34
23
220
(40768800) Prostate Pathology biopsy report
36
373
0.96
0.04
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
49
504
0.97
0.04
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
160
0.94
0.04
1.3
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
131
1.07
0.03
1.8
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
32
329
0.97
0.02
1.4
1.2
u/ml
71.6
28.9
—
6
16
(3049717) Cytology report of Urine Cyto stain
70
710
0.99
0.02
2.9
2.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
27
276
0.98
0.00
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
386
0.98
0.00
2.4
2.4
ug/min
78.7
103.1
0.32
29
235
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
12
115
1.04
0.00
1.2
1.1
—
61.3
—
0
12
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
36.0
—
0
6
(1617658) Protocol used for examination of sentinel lymph nodes
8
89
0.90
0.00
1.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
63
0.95
0.00
2.5
3.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
70
1.00
0.00
1.3
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
51
0.98
0.00
1.2
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.8
—
0
6
(44806420)
6
59
1.02
0.00
3.3
2.4
—
—
—
0
0
(4211845)
6
69
0.87
0.00
2.5
3.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
1484.2
—
0
6
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
9.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
5
54
0.93
0.00
1.8
2.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
52
0.96
0.00
2.2
2.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
335.2
—
0
6
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_MULTIPLE_MYELOMA_PLASMA_CELL – Multiple myeloma and malignant plasma cell neoplasms
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).